Perrigo Company plc

PRGO

CIK 0001585364 · Quarterly mode · latest period FY2025 (Q4) (ending 2025-12-31) · sourced from SEC EDGAR

At a glance · FY2025 (Q4)

Revenue
$1.11B
↓-2.5% -$29Mvs FY2024 (Q4)
Operating Income
$255M
↑+683.1% +$222Mvs FY2024 (Q4)
Net Income
$172M
Gross Profit
$362M
↓-6.1% -$24Mvs FY2024 (Q4)

Quality Score

Quality score

6-dimension fundamental snapshot · latest annual filed values · S&P 500 calibration

Average
45/100
  • Profitability
    0ROIC -12.3% (10% = solid, 20%+ = moat)
  • Liquidity
    100Current Ratio 2.76 (above 1.5 = solid)
  • Leverage
    39D/E 1.23 (under 0.5 = conservative)
  • Efficiency
    21Asset Turnover 0.47x (1.0+ = capital-efficient)
  • Growth
    8Revenue YoY -2.5% (10% = solid, 25%+ = elite)
  • Margin Trend
    100Op Margin 7.0% · trend +4.6pts (4Q avg vs prior 4Q)

Calibrated to S&P 500 medians. Each sub-score is computed from a single CFA-grade ratio (Profitability = ROIC, Liquidity = Current Ratio, Leverage = D/E, Efficiency = Asset Turnover, Growth = Revenue YoY, Margin Trend = 4Q operating-margin avg vs prior 4Q). Overall = simple mean.

DCF intrinsic value

DCF intrinsic value

two-stage Gordon model

Project PRGO's free cash flow forward, discount back at your hurdle rate, divide by diluted shares. Edit the assumptions to see how sensitive the intrinsic value is.

3%

Trailing 3-yr CAGR was -11.7%

10%

10% is a common all-equity benchmark for US large-caps

2.5%

Should be ≤ long-run GDP growth (~2.5% nominal)

5

5-year explicit projection + perpetuity terminal

Intrinsic value per share
$14.63
Total enterprise IV
$2.03B
Diluted shares
0.14B
Terminal PV
$1.43B (70% of total)
Year-5 FCF
$168M
YearProjected FCFDiscounted PV
+1$149M$136M
+2$154M$127M
+3$159M$119M
+4$163M$112M
+5$168M$104M
Terminal$2.30B$1.43B

DCF outputs are HIGHLY sensitive to growth + WACC assumptions. A 1pp WACC change can shift IV by 20%+. Use this as a sanity-check vs market price, not a target — and always cross-check the underlying FCF source (EDGAR cashflow statement, latest annual). Margin of safety convention: 30-50% discount to IV before buying.

Capital allocation · trailing 4 quarters

how the company spent its cash
Capex (TTM)
$93M
investment in PP&E
Dividends paid (TTM)
$159M
cash returned to holders
Stock buybacks (TTM)
share count reduction
Stock-based comp (TTM)
$55M
non-cash dilution

Balance sheet · 2025-12-31

latest filed snapshot
Total assets
$8.54B
everything owned
Total liabilities
$5.60B
everything owed
Stockholders' equity
$2.94B
shareholder claim
Net debt
$3.17B
LT debt minus cash

Recent performance · 58 quarters

Revenue↓-2.5% -$29M
$1.11B
Net Income↑+135.7% +$29M
$8M
Free Cash Flow↓-45.9% -$126M
$149M
Operating Margin↓-0.4pts
7.0%

Drill down